Shahverdi Sheida, Hajimiri Mirhamed, Esfandiari Mohammad Amin, Larijani Bagher, Atyabi Fatemeh, Rajabiani Afsaneh, Dehpour Ahmad Reza, Gharehaghaji Ali Akbar, Dinarvand Rassoul
Nanomedicine and Biomaterial Lab, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Nanomedicine and Biomaterial Lab, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Nano Alvand Co., Avicenna Tech Park, Tehran University of Medical Sciences, Tehran, Iran.
Int J Pharm. 2014 Oct 1;473(1-2):345-55. doi: 10.1016/j.ijpharm.2014.07.021. Epub 2014 Jul 19.
Silk fibroin (SF) and poly(lactide-co-glycolic acid) (PLGA) have been proved to be invaluable polymers in the field wound healing. This study aims at optimizing the electrospinning process of those polymers to make a hybrid membrane as a chronic wounds dressing. After characterizing the scaffolds, PLGA/SF (2:1), and PLGA scaffolds were selected for further study according to their superior tensile mechanical properties. The attachment and proliferation of mouse fibroblasts (L929) on scaffolds were measured using colorimetric assay and scanning electron microscopy. Furthermore, to evaluate the wound healing effect of the scaffolds in comparison with gauze and Comfeel(®) dressings, an excision wound model was conducted on diabetic rats. On the postoperative days of 3, 6, 9, 12, and 15, residual wound area was calculated using macroscopic data. In vitro results showed that the attachment and proliferation of L929 were significantly increased on PLGA/SF (2:1) hybrid scaffold. Animal study and histopathological evaluation outcomes confirmed the in vitro results as well. On day 15, the residual wound area in PLGA/SF (2:1) hybrid membrane group was significantly smaller than PLGA and control groups. This promising scaffold has the potential to be used for the upcoming development of wound dressings with or without biological drugs.
丝素蛋白(SF)和聚乳酸-乙醇酸共聚物(PLGA)已被证明是伤口愈合领域中非常重要的聚合物。本研究旨在优化这些聚合物的静电纺丝工艺,以制备一种混合膜作为慢性伤口敷料。在对支架进行表征后,根据PLGA/SF(2:1)和PLGA支架优异的拉伸力学性能,选择它们进行进一步研究。使用比色法和扫描电子显微镜测量小鼠成纤维细胞(L929)在支架上的附着和增殖情况。此外,为了与纱布和康惠尔(Comfeel®)敷料相比评估支架的伤口愈合效果,在糖尿病大鼠上建立了切除伤口模型。在术后第3、6、9、12和15天,使用宏观数据计算残余伤口面积。体外结果表明,L929在PLGA/SF(2:1)混合支架上的附着和增殖显著增加。动物研究和组织病理学评估结果也证实了体外结果。在第15天,PLGA/SF(2:1)混合膜组的残余伤口面积明显小于PLGA组和对照组。这种有前景的支架有潜力用于未来含或不含生物药物的伤口敷料的开发。